X-37

X-37, LLC is a pharmaceutical discovery and development company based in South San Francisco, California, founded in 2018. The company specializes in addressing cancer, autoimmune diseases, and coagulation disorders. Utilizing advanced artificial intelligence technology from Atomwise, Inc., X-37 focuses on discovering novel drug candidates by screening extensive libraries of chemical compounds against significant pharmaceutical targets. This innovative approach aims to expedite the discovery and development of medicines, ultimately benefiting the healthcare sector and improving patient outcomes.